Viewing Study NCT06481956

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:16 PM
Ignite Modification Date: 2026-02-01 @ 7:46 PM
Study NCT ID: NCT06481956
Status: ENROLLING_BY_INVITATION
Last Update Posted: 2024-07-01
First Post: 2024-06-25
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: T-DM1 Combined With CDK4/6 Inhibitor Ribociclib
Sponsor: Zheng Yabing
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HER2-positive Advanced Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None HER2-positive View
None Advanced breast cancer View
None Trastuzumab Emtansine View
None Ribociclib View